Self-amplifying RNA (saRNA)

Revolutionizing Vaccine Development

Rapid response to emerging diseases is critical when developing a vaccine. Long RNA (mRNA and saRNA) is at the forefront of vaccine development.

Benefits of saRNA
  • saRNA vaccines can be developed in a fraction of the time it takes to develop a conventional vaccine
  • Manufacturing is cell-free, does not require a dedicated facility
  • saRNA vaccines often produce a higher immune response from a smaller dose when compared to mRNA based vaccines


Related News

Webinar: Comprehensive GMP Manufacturing of mRNA-LNP Drug Products: Sequence-to-Vial

The manufacture and release of mRNA therapeutics and vaccines is a complex and challenging process requiring a high degree of expertise,...

Meeting mRNA Demand

Demand for mRNA continues to rise and earlier this Spring, we announced the expansion of our mRNA custom manufacturing— going from a cell bank to a...

Aldevron Announces Expansion of mRNA Production Capability

Will offer mRNA cGMP Production from Master Cell Bank to Drug Product Made Possible with Precision Nanosystems and Cytiva Aldevron, a leading global...

Related Blog Posts

LNPs, analytics and mRNA

Working toward advanced analytical techniques Guten tag from Berlin! As an analytically minded-person, it’s fascinating to connect with colleagues...